Jacopo Ceolan1,2*, Katie Seu, PhD2,3, Athina Ntoumaziou, MD2*, Yasmin Elgammal, MD, MSc2*, Sana Emberesh4*, Lisa Bilston, MD5, Donald Richards, MD6*, Kathryn E. Dickerson, MD, MS7, Satheesh Chonat, MD8, Natalia Rydz, MD, FRCPC5, Carolyn Lutzko, PhD2,3*, Ammar Husami9*, Wenying Zhang3,10* and Theodosia A. Kalfa, MD, PhD2,3
1Department of Medicine, University of Verona, Verona, Italy
2Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
4Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
5Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, Canada
6Northeast Texas Cancer and Research Institute, Tyler, TX
7Division of Hematology & Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
8Department of Pediatrics, Emory University School of Medicine and Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA
9Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
10Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH